Sei Investments Co. trimmed its holdings in HealthEquity, Inc. (NASDAQ:HQY – Free Report) by 9.9% during the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 602,721 shares of the company’s stock after selling 66,224 shares during the quarter. Sei Investments Co.’s holdings in HealthEquity were worth $50,369,000 at the end of the most recent reporting period.
A number of other institutional investors have also modified their holdings of HQY. Fifth Third Wealth Advisors LLC lifted its holdings in shares of HealthEquity by 4.2% in the 1st quarter. Fifth Third Wealth Advisors LLC now owns 2,872 shares of the company’s stock valued at $240,000 after buying an additional 116 shares during the period. Truist Financial Corp raised its position in HealthEquity by 4.9% during the fourth quarter. Truist Financial Corp now owns 2,537 shares of the company’s stock valued at $232,000 after acquiring an additional 119 shares in the last quarter. Fiduciary Trust Co raised its position in HealthEquity by 3.4% during the third quarter. Fiduciary Trust Co now owns 3,669 shares of the company’s stock valued at $348,000 after acquiring an additional 120 shares in the last quarter. Larson Financial Group LLC lifted its holdings in HealthEquity by 24.4% in the third quarter. Larson Financial Group LLC now owns 628 shares of the company’s stock valued at $60,000 after acquiring an additional 123 shares during the period. Finally, GAMMA Investing LLC lifted its holdings in HealthEquity by 9.5% in the fourth quarter. GAMMA Investing LLC now owns 1,944 shares of the company’s stock valued at $178,000 after acquiring an additional 168 shares during the period. Hedge funds and other institutional investors own 99.55% of the company’s stock.
Insider Activity at HealthEquity
In related news, EVP Michael Henry Fiore sold 2,354 shares of the company’s stock in a transaction dated Friday, July 10th. The shares were sold at an average price of $95.00, for a total transaction of $223,630.00. Following the completion of the sale, the executive vice president owned 52,244 shares of the company’s stock, valued at approximately $4,963,180. This represents a 4.31% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Delano Ladd sold 7,500 shares of the stock in a transaction dated Thursday, May 28th. The shares were sold at an average price of $90.00, for a total transaction of $675,000.00. Following the completion of the sale, the executive vice president owned 91,141 shares of the company’s stock, valued at approximately $8,202,690. The trade was a 7.60% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders sold 17,905 shares of company stock valued at $1,651,280. Corporate insiders own 1.60% of the company’s stock.
Analyst Ratings Changes
Read Our Latest Stock Report on HQY
HealthEquity Stock Up 0.3%
Shares of NASDAQ HQY opened at $94.64 on Friday. The company’s 50-day simple moving average is $90.21 and its 200-day simple moving average is $84.94. HealthEquity, Inc. has a 52-week low of $72.76 and a 52-week high of $105.96. The firm has a market cap of $7.91 billion, a price-to-earnings ratio of 35.45, a price-to-earnings-growth ratio of 1.59 and a beta of 0.21. The company has a quick ratio of 3.44, a current ratio of 3.44 and a debt-to-equity ratio of 0.46.
HealthEquity (NASDAQ:HQY – Get Free Report) last issued its quarterly earnings results on Thursday, May 28th. The company reported $1.24 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.11 by $0.13. HealthEquity had a return on equity of 14.75% and a net margin of 17.25%.The firm had revenue of $354.64 million for the quarter, compared to analyst estimates of $352.02 million. The firm’s quarterly revenue was up 7.2% compared to the same quarter last year. HealthEquity has set its FY 2027 guidance at 2.880-2.950 EPS. Equities analysts predict that HealthEquity, Inc. will post 3.92 EPS for the current fiscal year.
HealthEquity Company Profile
HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.
Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.
Further Reading
- Five stocks we like better than HealthEquity
- Telecom Earnings Reveal a Sector That Finally Looks Healthier
- Defense Earnings Show Readiness Now and Modernization Ahead
- Why Palantir Investors Aren’t Panicking While the Rest of AI Sells Off
- MarketBeat Week in Review – 07/20- 07/24
Want to see what other hedge funds are holding HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthEquity, Inc. (NASDAQ:HQY – Free Report).
Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.
